Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam for bile acid composition and glucose metabolism in impaired fasting glucose or newly diagnosed type 2 diabetes
NL-OMON33057Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial in impaired fasting glucose (IFG) and type 2 diabetes mellitus (T2DM) comparing Colesevelam with Placebo (2 arms). Status: withdrawn.
02
Drugs
colesevelam
03
Conditions
impaired fasting glucose (IFG)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON33057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33057.